[1]Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: inernational guidelines for management of severe sepsis and septic shock: 2012 [J]. Crit, 2013, 41(2): 580-637. [2]李立斌, 严静. 脓毒症的生物标记物:过去、现在和未来 [J]. 中华急诊医学杂志, 2013, 22(9): 954-956. [3]Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international interna sepsis definitions conference [J]. Crit Care Med, 2003, 31(4): 1250-1256. [4]李鹏声, 梁融, 周舒冬, 等. 应用logistic回归模型间接估计RR/PR的方法探讨[J]. 中国卫生统计, 2014, 31(6): 949-951. [5]Jose L, Paulo F, Sofia J, et a1. Long-term risk of mortality after acute kidney injury in patietns with sepsis: a contemporary analysis [J]. BMC Nephrol, 2010, 11(2): 9. [6]范泉, 张泓. 脓毒症患者预后危险因素的Logistic回归分析[J]. 安徽医科大学学报, 2014, 49(10): 1479-1481. [7]王娇, 刘雪燕, 方红辉. 影响血培养阳性脓毒症临床预后及转归的相关因素[J]. 中国实用医刊, 2015, 42(13): 96-97. [8]潘爱军, 邓艳如, 杨田军, 等. 脓毒症外周血自然杀伤细胞表型和功能及其临床意义 [J].中华危重病急救医学, 2014, 26(11): 827-831. [9]韩静, 邱俏檬, 吴斌, 等. 脓毒症并发急性肾损伤患者临床特及预后因素分析[J]. 中华危重医学杂志(电子版), 2014, 7(1): 30-33. [10]刘娟, 苏震, 张周沧. 脓毒症合并急性肾损伤患者发病及预后的多因素分析[J]. 中华医学杂志, 2011, 91(16): 1112-1114. [11]曹书华. 脓毒症与多脏器功能失常综合征[J]. 中华急诊医学杂志, 2010, 19(7): 781 -782. [12]Chan T, Gu F. Early diagnosis of sepsis using serum biomarkers [J]. Expert Rev Mol Diagn, 2011, 11(5): 487 -496. [13]Berger B, Gumbinger C, Steiner T, et al. Epidemiologic features, risk factors, and outcome of sepsis in stroke patients treated on aneurologic intensive care unit [J]. J Crit Care, 2014, 29(2): 241-248.
|